Cancer Letters
Volume 291, Issue 2 , Pages 177-186 , 28 May 2010

PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cells

  • Jian Yu

      Affiliations

    • The First Affiliated Hospital of Zhejiang University Medical School, Hangzhou 310003, China
    • Anhui Key Laboratory for Cellular Dynamics and Chemical Biology and National Laboratory for Physical Sciences at Nanoscale, Hefei 230027, China
    • These authors contributed equally to this work.
    • ,
  • Jianping Lan

      Affiliations

    • The First Affiliated Hospital of Zhejiang University Medical School, Hangzhou 310003, China
    • Department of Hematology, Zhejiang Provincial People’s Hospital, Hangzhou 310014, China
    • Anhui Key Laboratory for Cellular Dynamics and Chemical Biology and National Laboratory for Physical Sciences at Nanoscale, Hefei 230027, China
    • These authors contributed equally to this work.
    • ,
  • Chong Wang

      Affiliations

    • The First Affiliated Hospital of Zhejiang University Medical School, Hangzhou 310003, China
    • ,
  • Quan Wu

      Affiliations

    • Anhui Key Laboratory for Cellular Dynamics and Chemical Biology and National Laboratory for Physical Sciences at Nanoscale, Hefei 230027, China
    • ,
  • Yuanyuan Zhu

      Affiliations

    • The First Affiliated Hospital of Zhejiang University Medical School, Hangzhou 310003, China
    • ,
  • Xiaoyu Lai

      Affiliations

    • The First Affiliated Hospital of Zhejiang University Medical School, Hangzhou 310003, China
    • ,
  • Jie Sun

      Affiliations

    • The First Affiliated Hospital of Zhejiang University Medical School, Hangzhou 310003, China
    • ,
  • Changjiang Jin

      Affiliations

    • Anhui Key Laboratory for Cellular Dynamics and Chemical Biology and National Laboratory for Physical Sciences at Nanoscale, Hefei 230027, China
    • Corresponding Author InformationCorresponding authors. Tel./fax: +86 571 8723 6706 (H. Huang), +86 551 360 7141 (C. Jin).
    • ,
  • He Huang

      Affiliations

    • The First Affiliated Hospital of Zhejiang University Medical School, Hangzhou 310003, China
    • Corresponding Author InformationCorresponding authors. Tel./fax: +86 571 8723 6706 (H. Huang), +86 551 360 7141 (C. Jin).

Received 17 May 2009 ,Revised 11 October 2009 ,Accepted 13 October 2009.

References 

  1. de Lange T. Protection of mammalian telomeres. Oncogene. 2002;21:532–540
  2. Blackburn EH. Structure and function of telomeres. Nature. 1991;350:569–673
  3. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 1973;41:181–190
  4. Allsopp RC, Chang E, Kashefi-Aazam M, Rogaev EI, Piatyszek MA, Shay JW, et al. Telomere shortening is associated with cell division in vitro and in vivo. Exp. Cell Res. 1995;220:194–200
  5. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer. 1997;33:787–791
  6. Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. Telomeres elongation in immortal human cells without detectable telomerase activity. EMBO J. 1995;14:4240–4248
  7. Muntoni A, Reddel RR. The first molecular details of ALT in human tumor cells. Hum. Mol. Genet. 2005;14:R191–R196
  8. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 1999;59:4175–4179
  9. Wu G, Jiang X, Lee W-H, Chen P-L. Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1. Cancer Res. 2003;63:2589–2595
  10. Johnson FB, Marciniak RA, McVey M, Stewart SA, Hahn WC, Guarente L. The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J. 2001;20:905–913
  11. Stavropoulos DJ, Bradshaw PS, Li X, Pasic I, Truong K, Ikura M, et al. The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum. Mol. Genet. 2002;11:3135–3144
  12. Yankiwski V, Marciniak RA, Guarente L, Neff NF. Nuclear structure in normal and Bloom syndrome cells. Proc. Natl. Acad. Sci. USA. 2000;97:5214–5219
  13. Wu G, Lee W-H, Chen P-L. NBS1 and TRF1 colocalize at promyelocytic leukemia bodies during late S/G2 phases in immortalized telomerase-negative cells. J. Biol. Chem. 2000;275:30618–30622
  14. Naka K, Ikeda K, Motoyama N. Recruitment of NBS1 into PML oncogenic domains via interaction with SP100 protein. Biochem. Biophys. Res. Commun. 2002;299:863–871
  15. Jiang W-Q, Zhong Z-H, Henson JD, Reddel RR. Identification of candidate alternative lengthening of telomeres genes by methionine restriction and RNA interference. Oncogene. 2007;26:4635–4647
  16. Fan Q, Zhang F, Barrett B, Ren K, Andreassen PR. A role for monoubiquitinated FANCD2 at telomeres in ALT cells. Nucleic Acids Res. 2009;37:1740–1754
  17. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005;19:2100–2110
  18. Potts PR, Yu H. The SMC5/6 complex maintains telomere length in ALT cancer cells through sumoylation of telomere-binding proteins. Nat. Struct. Mol. Biol. 2007;14:581–590
  19. Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood. 1999;93:3167–3215
  20. Bernardi R, Pandolfi PP. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 2007;8:1006–1016
  21. Jensen K, Shiels C, Freemont PS. PML protein isoforms and the RBCC/TRIM motif. Oncogene. 2001;20:7223–7233
  22. Fogal V, Gostissa M, Sandy P, Zacchi P, Sternsdorf T, Jensen K, et al. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 2000;19:6185–6195
  23. Wu Q, Hu H, Lan J, Emenari C, Wang Z, Chang KS, et al. PML3 orchestrates the nuclear dynamics and function of TIP60. J. Biol. Chem. 2009;284:8747–8759
  24. Liu D, Zhang N, Du J, Cai X, Zhu M, Jin C, et al. Interaction of Skp1 with CENP-E at the midbody is essential for cytokinesis. Biochem. Biophys. Res. Commun. 2006;345:394–402
  25. Zhang N, Liu J, Ding X, Aikhionbare F, Jin C, Yao X. FBXL5 interacts with p150Glued and regulates its ubiquitination. Biochem. Biophys. Res. Commun. 2007;359:34–39
  26. Yu J, Lan J, Zhu Y, Li X, Lai X, Xue Y, et al. The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of Tara. Biochem. Biophys. Res. Commun. 2008;367:805–812
  27. Li X, Lan J, Zhu Y, Yu J, Dou Z, Huang H. Expression, purification, and characterization of Tara, a novel telomere repeat-binding factor 1 (TRF1)-binding protein. Protein Expres. Purif. 2007;55:84–92
  28. Xu Z-X, Zou W-X, Lin P, Chang K-S. A role for PML3 in centrosome duplication and genome stability. Mol. Cell. 2005;17:721–732
  29. Yao X, Abrieu A, Zheng Y, Sullivan KF, Cleveland DW. CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint. Nat. Cell Biol. 2000;2:484–491
  30. Fu C, Ahmed K, Ding H, Ding X, Lan J, Yang Z, et al. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3. Oncogene. 2005;24:5401–5413
  31. Grobelny JV, Godwin AK, Broccoli D. ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. J. Cell Sci. 2000;113:4577–4585
  32. Dunham MA, Neumann AA, Fasching CL, Reddel RR. Telomere maintenance by recombination in human cells. Nat. Genet. 2000;26:447–450
  33. Perrem K, Colgin LM, Neumann AA, Yeager TR, Reddel RR. Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells. Mol. Cell Biol. 2001;21:3862–3875
  34. Jiang W-Q, Zhong Z-H, Henson JD, Neumann AA, Chang AC, Reddel RR. Suppression of alternative lengthening of telomeres by Sp100-mediated sequestration of the MRE11/RAD50/NBS1 complex. Mol. Cell Biol. 2005;25:2708–2721
  35. Zhong Z-H, Jiang W-Q, Cesare AJ, Neumann AA, Wadhwa R, Reddel RR. Disruption of telomere maintenance by depletion of the MRE11/RAD50/NBS1 complex in cells that use alternative lengthening of telomeres. J. Biol. Chem. 2007;282:29314–29322

PII: S0304-3835(09)00631-4

doi: 10.1016/j.canlet.2009.10.009

Cancer Letters
Volume 291, Issue 2 , Pages 177-186 , 28 May 2010

Article Tools

* Image Usage & Resolution